VICARDIA
ViCardia is ledmanagement team, board of directors and board of scientific advisors with extensive experience treating chronic and acute heart failure and conducting cardiovascular research. The company focused on the discovery, development and commercialization of novel therapies for treating heart failure involving mitochondrial dysfunction.
VICARDIA
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2017-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.vicardia.com
Total Employee:
1+
Status:
Active
Contact:
+ 1 855 272 6727
Technology used in webpage:
Newfold Digital
Similar Organizations
Alpha Biopharma
Alpha Biophama is a clinical stage biopharmaceutical company.
Altavant Sciences
Altavant Sciences is a clinical-stage biopharmaceutical company.
Aramis Biosciences
Aramis Biosciences is an immuno-ophthalmology biopharmaceutical company.
Calcilytix Therapeutics
Calcilytix is a clinical-stage biopharmaceutical company.
Cellvation
Cellvation is a clinical stage biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
Tactical Therapeutics
Tactical Therapeutics is a clinical-stage company that develops therapeutics for cancer.
XEME Biopharma
XEME Biopharma is a clinical-stage pharmaceutical development business.
Official Site Inspections
http://www.vicardia.com
- Host name: 242.161.96.66.static.eigbox.net
- IP address: 66.96.161.242
- Location: Burlington United States
- Latitude: 42.509
- Longitude: -71.1984
- Metro Code: 506
- Timezone: America/New_York
- Postal: 01803
More informations about "ViCardia"
Home - ViCardia
ViCardia Therapeutics, Inc., a Delaware corporation, founded in 2017, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of …See details»
About Us - ViCardia
Mr. Kokesh is the founder of ViCardia Therapeutics, Inc. Prior work experience includes serving as the Chief Executive Officer of the Ischemia Research and Education Foundation, a leading cardiovascular institute. Mr. Kokesh has …See details»
ViCardia - Crunchbase Company Profile & Funding
ViCardia is ledmanagement team, board of directors and board of scientific advisors with extensive experience treating chronic and acute heart failure and conducting cardiovascular research. The company focused on the discovery, …See details»
Investors - ViCardia
Partnering with ViCardia Presents a Major Opportunity to Bring GP531 to Fruition . From the perspective of the hospital, physician, care-giver and the payor, the reduced number of …See details»
Vicardia Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Vicardia Therapeutics Inc. of San Francisco, CA. Get the latest business insights from Dun & Bradstreet.See details»
ViCardia Therapeutics - Products, Competitors, Financials, …
ViCardia Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies for heart failure, particularly targeting …See details»
ViCardia Therapeutics, Inc. | Life Sciences PA - Default Site
ViCardia Therapeutics, Inc., a Delaware corporation, founded in 2017, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of …See details»
ViCardia Therapeutics, Inc. - VentureRadar
" ViCardia Therapeutics Inc., a privately held company founded in 2017, based in San Francisco, is entering Phase 2 with GP531, a potent, long-lasting infusion therapy that treats …See details»
ViCardia Therapeutics, Inc. Profile - medical-xprt.com
ViCardia Therapeutics, Inc., a Delaware corporation, founded in 2017, is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of …See details»
ViCardia - Crunchbase
ViCardia is a clinical-stage biopharmaceutical company. Start Free Trial . Chrome ExtensionSee details»
ViCardia - Tech Stack, Apps, Patents & Trademarks - Crunchbase
ViCardia is a clinical-stage biopharmaceutical company. Start Free Trial . Chrome ExtensionSee details»
ViCardia Therapeutics - Overview, News & Similar companies
ViCardia is led by a highly experienced management team, board of directors and board of scientific advisors with extensive experience treating chr onic and acute heart failure and …See details»
VisCardia - Org Chart, Teams, Culture & Jobs - The Org
View VisCardia's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Michael Kokesh - BIO Investor Forum | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Mr. Kokesh is the founder of …See details»
Michael Kokesh, JD - BIO CEO & Investor Conference | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Mr. Kokesh is the founder of …See details»
Home | VisCardia
VisCardia Inc., a privately held medical device developer in Portland Oregon, is developing a new implantable device therapy for heart failure.See details»
Treating Mitochondrial Dysfunction: the Underlying Cause of …
ViCardia Therapeutics Inc. 75 Broadway, Suite 202 San Francisco, CA 94111 Office: 415 -661-1234. ext. 1 Mobile: 415-533-7008 [email protected]. Forward Looking Statements This …See details»
Clinicians - ViCardia
ViCardia and GP531 . ViCardia is entering Phase 2 with GP531, a potent, long-lasting, infusion therapy that treats mitochondrial dysfunction that leads to chronic heart failure and ultimately …See details»
ViCardia Therapeutics, Inc. - BIO Investor Forum | BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... ViCardia Therapeutics, a …See details»
Patients - ViCardia
In our Phase 2 clinical trial, ViCardia intends to show that GP531 improves patient outcomes post-discharge. If successful, GP531 would provide the clear pathway to a life-saving therapy for …See details»